Pharmafile Logo

Glaucoma in perspective

Lucid Group – Hanging tough in support of Wycombe Homeless Connection

This Saturday, 19 brave Lucidians took to the fields of Henley to conquer the first of Tough Mudder’s 2018 obstacle course events. The Tough Mudder course features 13 obstacles over...

Lucid Group Communications Limited

- PMLiVE

Sandoz targets digital therapeutics

Partners with Pear Therapeutics to launch FDA-approved apps

- PMLiVE

Concept Life Sciences adds to its team

Matilda Bingham and David Higton join its Alderley Park site

- PMLiVE

Unlimited Group rebrands

Brings 27 agencies together into seven disciplines

- PMLiVE

Understanding HCPs to build a meaningful brand

In the regulated world of pharmaceutical marketing,  how can a brand build a meaningful relationship with its customers? This article explores healthcare professionals’ (HCPs) perceptions of pharmaceutical companies, using analysis of...

- PMLiVE

NHS England’s Simon Stevens – no Trump drug price rhetoric here

Health service supremo will play major role in UK pricing talks

- PMLiVE

Redx poaches AstraZeneca senior executive

Lisa Anson joins the UK biotech as its CEO

- PMLiVE

Novartis launches remote clinical trial app

FocalView will allow patients to participate in ophthalmology trials

- PMLiVE

Morning brief: Sanofi’s shaky start, pharma begins talks with UK government and more

Sanofi falling behind in Amgen cholesterol battleFirst quarter results from Sanofi show the company has got off to shaky start in 2018, including signs that it its PCKS9 inhibitor cholesterol...

- PMLiVE

NHS chief pledges CAR-T support, but asks for pricing restraint

The plea comes as the EMA reviews two CAR-T therapies

Sanofi reception

Sanofi warns of difficult few months as diabetes sales slump

Dupixent sales fall compared to Q4 2017

Empowered patients improve outcomes

This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments and...

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links